|Articles|April 22, 2015
Dr. Primo Lara Discusses Emerging Therapies in Kidney Cancer
Primo Neary Lara Jr., associate director of Translational Research at the UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.
Advertisement
Primo Neary Lara Jr., associate director of Translational Research and co-leader of the Cancer Therapeutics Program at UC Davis Comprehensive Cancer Center, discusses emerging therapies for patients with kidney cancer.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
A New Option Without Traditional Chemotherapy for Ph+ ALL
2
Azacitidine Plus Venclexta Superior to Chemo in Acute AML
3
Jaypirca Matches Imbruvica's Effectiveness for CLL, With Hints of Long-Term Benefit
4
First Annual Blood Cancer Heroes Honors Leaders, Advocates and Survivors
5
